High systolic and pulse pressure levels are associated with better cognitive performance in patients with probable alzheimer's disease: A cross-sectional observational study in a geriatric outpatient population

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 4, 2009, Pages 320-324

  Van Bruchem Visser, Rozemarijn L ^a   Mattace Raso, Francesco U S ^a   Van Der Cammen, Tischa J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Blood pressure levels; Cardiovascular risk factors; Mini Mental State Examination (MMSE)

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; COGNITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GERIATRIC CARE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTPATIENTS; PSYCHOMOTOR PERFORMANCE;

EID: 70350046654     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000249146     Document Type: Article

References (23)

1. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R: Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005; 65: 545-551.
2. van Exel E, Gussekloo J, Houx P, et al: Atherosclerosis and cognitive impairment are linked in the elderly. The Leiden 85-plus Study. Atherosclerosis 2002; 165: 353-359.
3. Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ: Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2002; 57:M173-M177.
4. Skoog I, Lernfelt B, Landahl S, et al: 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-1145. (Pubitemid 126512042)
5. Guo Z, Viitanen M, Fratiglioni L, Winblad B: Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 1996; 312: 805-808.
6. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H: Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998; 31: 780-786.
7. Cacciatore F, Abete P, Ferrara N, et al: The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group. J Hypertens 1997; 15: 135-142.
8. Forette F, Seux ML, Staessen JA, et al: Prevention of dementia in randomised doubleblind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-1351.
9. Hanon O, Berrou JP, Negre-Pages L, et al: Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive Function and Systolic Blood Pressure Reduction openlabel study. J Hypertens 2008; 26: 1642-1650.
10. Oudshoorn C, Mattace-Raso FU, van der Velde N, Colin EM, van der Cammen TJ: Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25: 539-543.
11. Epstein AM, Hall JA, Besdine R, et al: The emergence of geriatric assessment units. The 'new technology of geriatrics'. Ann Intern Med 1987; 106: 299-303.
12. Folstein MF, Folstein SE, McHugh PR: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
13. Rooymans H: The psychiatrist in the general hospital: a review of consultative and liaison psychiatry; thesis, Utrecht University, The Netherlands, 1984.
14. International Classification of Diseases (9th rev) Utrecht: de Boer-Cuperus; 1986.
15. Van der Cammen TJ, Verschoor CJ, van Loon CP, et al: Risk of left ventricular dysfunction in patients with probable Alzheimer's disease with APOE & 4 allele. J Am Geriatr Soc 1998; 46: 962-967.
16. Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington DC, American Psychiatric Association, 1994.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
18. Skoog I: Highs and lows of blood pressure: a cause of Alzheimer's disease? Lancet Neurol 2003; 2: 334.
19. Rossor MN: Neurotransmitters and CNS disease. Dementia. Lancet 1982; 2: 1200-1204.
20. Esler MD, Lambert GW, Ferrier C, et al: Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp Hypertens 1995; 17: 409-423.
21. Szot P, White SS, Greenup JL, Leverenz JB, Peskind ER, Raskind MA: Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies. J Neurosci 2006; 26: 467-478.
22. Hofman A, Ott A, Breteler MM, et al: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151-154. (Pubitemid 27039193)
23. Tombaugh TN, McIntyre NJ: The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40: 922-935.